Dassault Systèmes to buy ArisGlobal for up to $2bn
Dassault Systèmes is acquiring ArisGlobal for up to $2 billion to integrate its AI-driven drug-safety software into its virtual-twin technology. This move aims to bolster Dassault's life sciences business, which has faced recent revenue declines and investor concerns about AI's impact on its core operations.